TARRYTOWN, N.Y., May 06, 2024 (GLOBE NEWSWIRE) Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: RBC Capital Markets Global Healthcare Conference at 9:00 a.m. ET on
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $9.55 EPS, expectations were $10.17. Regeneron Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to […]
First quarter 2024 revenues decreased 1% to $3.15 billion versus first quarter 2023; excluding RonapreveTM, revenues increased 7%First quarter 2024 Dupixent® global net sales increased 24% to.
TARRYTOWN, N.Y., April 01, 2024 Regeneron Pharmaceuticals, Inc. today announced that it will report its first quarter 2024 financial and operating results on Thursday, May 2, 2024, before the.
Regeneron To Report First Quarter 2024 Financial And Operating Results And Host Conference Call And Webcast On May 2, 2024 menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.